Endoscopy20 Nov 2024
A prospective multicenter study evaluated endoscopic ultrasonography-guided ethanol injections (EUS-EI) for treating small pancreatic neuroendocrine neoplasms (PNENs). Of the 25 patients treated, 76% achieved the primary endpoint compared to surgical outcomes, and 88% attained complete ablation at 1 and 6 months. Safety results were promising,…
HPB (Oxford)16 Nov 2024
Personalized Cancer Risk Thresholds Can Guide IPMN Surgery Decisions Clinicians found that optimal cancer risk thresholds (CRT) for surgery in patients with branch-duct intraductal papillary mucinous neoplasms (bd-IPMN) vary based on age, comorbidities, and tumor location. For a 60-year-old with mild comorbidities, surgery was favored…
Surg Endosc11 Nov 2024
A retrospective analysis involving 2,163 asymptomatic individuals revealed that small-sized magnetically controlled capsule gastroscopy (mccg) successfully detected gastrointestinal issues such as submucosal tumors (1.57%), polyps (15.16%), and ulcers (1.25%). Detection rates for polyps were notably higher in females and increased with age. The procedure was…
BMJ Open10 Nov 2024
Prophylactic closure of mucosal defects significantly reduces delayed bleeding and perforation risks following endoscopic resection, according to a systematic review and meta-analysis of 28 studies involving 11,383 patients. The closure group exhibited a 60% lower risk for delayed bleeding compared to non-closure (risk ratio: 0.40),…
Intestine and Lower Gastrointestinal Tract6 Nov 2024
A randomized controlled trial demonstrated that the double-balloon interventional platform (DBIP) markedly reduced mean procedure time for colorectal endoscopic submucosal dissection (ESD) to 88.6 minutes, compared to 139.5 minutes for traditional ESD—a 36.5% reduction. Additionally, DBIP-assisted ESD improved en-bloc resection rates and sutured defect closures…
Medicine (Baltimore)6 Nov 2024
Endoscopic submucosal dissection (ESD) is crucial for early gastric cancer (EGC) management, often necessitating additional gastrectomy in cases deemed non-curative. Analysis of 134 patients revealed key factors such as deep submucosal invasion and positive margins that led to further surgical intervention. Notably, independent risk factors…
Therap Adv Gastroenterol4 Nov 2024
A systematic review assessed the effectiveness of hepaticogastrostomy with antegrade stenting (hgas) compared to hepaticogastrostomy alone (hgs) for malignant biliary obstruction. Findings revealed pooled clinical success rates of 94% for hgas versus 88% for hgs, while re-intervention needs were significantly lower with hgas (OR=0.37). Although…
Surgical Endoscopy1 Nov 2024
EUS-guided gastroenterostomy has gained recognition as an effective alternative to surgical gastrojejunostomy and duodenal stenting for treating gastric outlet obstruction. Key advantages include reduced invasiveness, shorter hospital stays, and potentially improved patient outcomes. This comprehensive review highlights the evolved techniques and their comparative effectiveness, affirming…
Surgical Endoscopy30 Oct 2024
A clinical practice update presented vital guidance on per-oral endoscopic myotomy (POEM), emphasizing that extensive diagnostic evaluations are essential before treatment. It highlights POEM as the preferred option for type III achalasia, while also supporting laparoscopic Heller myotomy and pneumatic dilation for other types. Antibiotic…
Dig Endosc26 Oct 2024
In a study involving 450 achalasia patients undergoing peroral endoscopic myotomy (POEM), treatment outcomes were favorable across disease types, with efficacy rates of 97.9% and 94.2% at one and two years, respectively. However, the incidence of esophageal cancer varied significantly among types: 1% in straight,…